LEMBO, Serena
 Distribuzione geografica
Continente #
NA - Nord America 8.086
AS - Asia 4.973
EU - Europa 4.416
SA - Sud America 603
Continente sconosciuto - Info sul continente non disponibili 238
AF - Africa 78
OC - Oceania 9
Totale 18.403
Nazione #
US - Stati Uniti d'America 7.877
HK - Hong Kong 2.220
IT - Italia 2.094
SG - Singapore 1.201
FI - Finlandia 1.200
CN - Cina 576
BR - Brasile 450
VN - Vietnam 416
RU - Federazione Russa 252
FR - Francia 146
DE - Germania 126
UA - Ucraina 116
IE - Irlanda 111
KR - Corea 107
SE - Svezia 96
TR - Turchia 93
CA - Canada 91
IN - India 91
AR - Argentina 64
NL - Olanda 58
GB - Regno Unito 57
BD - Bangladesh 56
JP - Giappone 46
MX - Messico 41
PL - Polonia 27
AT - Austria 26
EC - Ecuador 24
CO - Colombia 23
IQ - Iraq 23
ES - Italia 22
ID - Indonesia 22
JM - Giamaica 16
PK - Pakistan 16
VE - Venezuela 15
ZA - Sudafrica 15
CH - Svizzera 14
MY - Malesia 13
PH - Filippine 13
CR - Costa Rica 10
KE - Kenya 10
PY - Paraguay 10
TN - Tunisia 10
UZ - Uzbekistan 10
AU - Australia 9
CZ - Repubblica Ceca 9
EG - Egitto 9
MA - Marocco 9
HN - Honduras 8
IL - Israele 8
LT - Lituania 8
TT - Trinidad e Tobago 8
DZ - Algeria 7
GT - Guatemala 7
JO - Giordania 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
SA - Arabia Saudita 6
GR - Grecia 5
HR - Croazia 5
PR - Porto Rico 5
PT - Portogallo 5
BG - Bulgaria 4
BH - Bahrain 4
CL - Cile 4
DK - Danimarca 4
ET - Etiopia 4
NI - Nicaragua 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
SV - El Salvador 4
AL - Albania 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IR - Iran 3
KW - Kuwait 3
LU - Lussemburgo 3
RO - Romania 3
RS - Serbia 3
SC - Seychelles 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
GP - Guadalupe 2
HU - Ungheria 2
LB - Libano 2
MK - Macedonia 2
MN - Mongolia 2
MU - Mauritius 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
BO - Bolivia 1
BS - Bahamas 1
Totale 18.143
Città #
Dallas 2.916
Hong Kong 2.215
Helsinki 1.180
San Jose 676
Singapore 568
Milan 513
Ann Arbor 465
Chandler 339
Ashburn 323
Princeton 298
Council Bluffs 280
Rome 232
Woodbridge 207
Houston 163
Beijing 150
Wilmington 136
The Dalles 122
Ho Chi Minh City 120
Jacksonville 119
Lauterbourg 119
Dublin 107
Moscow 90
Dong Ket 87
Naples 83
New York 79
Santa Clara 79
Izmir 78
Los Angeles 68
Hanoi 62
Munich 51
Salerno 51
Andover 50
São Paulo 47
Nanjing 46
Boardman 40
Turin 40
Pellezzano 39
Tokyo 39
Figino 35
Bari 29
Phoenix 29
Amsterdam 27
Montreal 26
Seattle 26
Genoa 25
Nuremberg 25
Orem 25
Stockholm 25
Brooklyn 24
Columbus 24
Redwood City 24
Warsaw 24
Chicago 23
Hebei 23
Chennai 21
Fairfield 21
Palermo 21
San Francisco 21
Bologna 20
Denver 20
Florence 20
Frankfurt am Main 20
Rio de Janeiro 20
Da Nang 18
Shenyang 18
Fisciano 17
London 17
Seoul 17
Atlanta 16
Changsha 16
Mexico City 16
Haiphong 15
Mumbai 15
Norwalk 15
Boston 14
Curitiba 14
Toronto 14
Turku 14
Verona 14
Catania 13
Pune 12
Charlotte 11
Messina 11
Napoli 11
Philadelphia 11
Quito 11
Belo Horizonte 10
Cava de' Tirreni 10
Las Vegas 10
Vienna 10
Baghdad 9
Buffalo 9
Kingston 9
Thái Nguyên 9
Venice 9
Albignasego 8
Brasília 8
Istanbul 8
Nanchang 8
San José 8
Totale 13.330
Nome #
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 4.002
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 917
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 500
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 454
Automatic psoriasis assessment methods: Current scenario and perspectives from a metrologic point of view 340
Systemic Treatment of Pediatric Psoriasis: A Review 305
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 259
Psoriasi eritrodermica: rapida efficacia di bimekizumab 218
Anti-inflammatory properties of low and high doxycycline doses: An in vitro study 214
Farsi promotori di salute: “Safe Sun Coast” 187
The anti-inflammatory and antioxidant properties of 1,2-decanediol and willow bark extract in lipopolysaccharide-stimulated keratinocytes 182
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 179
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 158
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 154
IL-36 cytokines are increased in acne and hidradenitis suppurativa 151
Phenolics from Castanea sativa leaves and their effects on UVB-induced damage 149
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 145
Effectiveness and Tolerability of a Patch Containing Onion Extract and Allantoin for Cesarean Section Scars 138
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 137
Un ingrediente fitoattivo da scarti di Castanea sativa 136
Photodermatoses 133
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 132
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 131
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 125
Milk thistle and olive extract: old substances with a new mission against sun-induced skin damage 123
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 123
Atopic dermatitis: Epidemiology and clinical phenotypes 122
Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation 119
Presence of BAG3 protein in serum samples from patients affected by psoriasis 117
The modulatory effect of ellagic acid and rosmarinic acid on ultraviolet-B-induced cytokine/chemokine gene expression in skin keratinocyte (HaCaT) cells 117
Interleukin-33: increasing role in dermatological conditions 116
Photosensitivity and cancer immune-targeted therapies 115
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 114
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis 112
Fotodermatosi 112
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 111
Surprise from skin nodules after travel to South America 109
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 107
Toilet contact dermatitis 104
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 104
The effect of visible blue light on the differentiation of dendritic cells in vitro 102
Aberrant gene expression with deficient apoptotic keratinocyte clearance may predispose to polymorphic light eruption 102
Abnormal isoaspartyl residues in erythrocyte membranes from psoriatic patients 102
Polymorphic light eruption and skin cancer prevalence: Is one protective against the other? 97
A New Light on the Dark DNA Damages 97
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 96
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 95
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 95
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 94
Skin cancer overview. Chapter I: Photodermatoses and skin cancer. 94
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 93
Cancrum oris in a boy with Down syndrome 93
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 92
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 91
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 90
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 89
Pizza makers' contact dermatitis 86
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 85
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 84
IL-33 is regulated by TNF-α in normal and psoriatic skin 84
"Active" photoprotection: Sunscreens with DNA repair enzymes 84
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 82
Professional's and non-professional's papular urticaria caused by Scleroderma domesticum 81
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 80
Clinical predictors of psoriatic arthritis and osteoclast differentiation 80
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 79
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 79
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 79
IL-26 in allergic contact dermatitis: Resource in a state of readiness 78
Psoriasis in melanoma patients: a prospective pilot study 75
Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway 74
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 74
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study 71
Mammalian target of rapamycin in inflammatory skin conditions 71
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 70
Polymorphic light eruption: What's new in pathogenesis and management 70
Contact sensitization of children referred to the Dermatology Department of the University Federico II of Naples, Italy: a two-decade years history 69
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 69
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity 67
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 67
null 67
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 66
null 65
null 64
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 64
null 63
IL-26: A new actor in allergic contact dermatitis 63
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 62
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study 62
Nicotinamide reduces cyclooxygenase-2 expression in HaCaT keratinocytes after ultraviolet-B irradiation 61
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 60
null 60
Sporotrichosis: long-term treatment and follow-up in a diabetic patient from Southern Italy 60
Crack abuse-induced recalcitrant ulcers 60
Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: A possible metabolic loop 59
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study 58
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 58
null 58
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 58
Photodermatoses and Skin Cancer 57
Totale 15.856
Categoria #
all - tutte 55.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022476 0 0 0 12 30 5 5 18 56 47 75 228
2022/2023910 89 64 24 114 86 175 6 103 157 15 51 26
2023/2024688 45 80 38 32 48 54 36 44 21 79 61 150
2024/20251.966 95 39 132 157 93 242 229 124 332 120 186 217
2025/202611.103 302 2.108 3.174 449 661 295 922 250 1.448 610 188 696
2026/20271.392 273 188 460 471 0 0 0 0 0 0 0 0
Totale 18.403